DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $816,001 | +1.3% | 3,289 | -2.1% | 0.08% | +3.9% |
| Q2 2023 | $805,920 | -4.3% | 3,358 | +0.5% | 0.08% | -11.5% |
| Q1 2023 | $842,318 | +91555.9% | 3,342 | -3.4% | 0.09% | -17.9% |
| Q4 2022 | $919 | -99.9% | 3,459 | 0.0% | 0.11% | -0.9% |
| Q3 2022 | $894,000 | +1.1% | 3,459 | -0.9% | 0.11% | +9.2% |
| Q2 2022 | $884,000 | -21.5% | 3,489 | -9.2% | 0.10% | -10.1% |
| Q1 2022 | $1,126,000 | -4.2% | 3,841 | +7.5% | 0.11% | -2.7% |
| Q4 2021 | $1,175,000 | +8.7% | 3,572 | +0.6% | 0.11% | 0.0% |
| Q3 2021 | $1,081,000 | +13.4% | 3,551 | 0.0% | 0.11% | +10.9% |
| Q2 2021 | $953,000 | +96.9% | 3,551 | +1.5% | 0.10% | +12.2% |
| Q1 2021 | $484,000 | -38.0% | 3,499 | -0.5% | 0.09% | -12.6% |
| Q4 2020 | $781,000 | +4.0% | 3,517 | +0.9% | 0.10% | -8.8% |
| Q3 2020 | $751,000 | +21.5% | 3,487 | -0.2% | 0.11% | +17.7% |
| Q2 2020 | $618,000 | -48.0% | 3,495 | -57.5% | 0.10% | -3.0% |
| Q1 2020 | $1,188,000 | +115.6% | 8,226 | +128.9% | 0.10% | +16.5% |
| Q4 2019 | $551,000 | -7.2% | 3,593 | -12.6% | 0.08% | -14.1% |
| Q3 2019 | $594,000 | +3.3% | 4,113 | +2.1% | 0.10% | -1.0% |
| Q2 2019 | $575,000 | +3.0% | 4,027 | -4.8% | 0.10% | -2.9% |
| Q1 2019 | $558,000 | +28.0% | 4,229 | -0.1% | 0.10% | +15.7% |
| Q4 2018 | $436,000 | -6.4% | 4,233 | -1.2% | 0.09% | +18.7% |
| Q3 2018 | $466,000 | +10.2% | 4,283 | 0.0% | 0.08% | +2.7% |
| Q2 2018 | $423,000 | +0.7% | 4,283 | 0.0% | 0.07% | -2.7% |
| Q1 2018 | $420,000 | +9.4% | 4,283 | +3.6% | 0.08% | +4.2% |
| Q4 2017 | $384,000 | -22.0% | 4,136 | -27.8% | 0.07% | -12.2% |
| Q3 2017 | $492,000 | +1.9% | 5,729 | +0.1% | 0.08% | -6.8% |
| Q2 2017 | $483,000 | +1.3% | 5,724 | +2.7% | 0.09% | -7.4% |
| Q1 2017 | $477,000 | +8.9% | 5,576 | +28.5% | 0.10% | -17.4% |
| Q2 2016 | $438,000 | +4.8% | 4,340 | -1.7% | 0.12% | -8.7% |
| Q1 2016 | $418,000 | +703.8% | 4,415 | +612.1% | 0.13% | +600.0% |
| Q1 2015 | $52,000 | – | 620 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |